Compare Nasdaq100 ETF (QQQ) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq100 ETF vs 10X Genomics Inc — how do they compare? Nasdaq100 ETF trades at $714.04, while 10X Genomics Inc trades at $67.74 (market cap $8.77B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, Nasdaq100 ETF nearer its low. Which is the better fit depends on your goals.
| QQQ | TXG | |
|---|---|---|
52-Week High | $746.16 | $67.29 |
52-Week Low | $558.34 | $11.34 |
Market Cap | — | $8.77B |
Sector | — | Health |
Enterprise Value | — | $8.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QQQ trades at $718.36, down slightly by 0.08% on the day, with a bullish technical outlook from moving averages and neutral oscillators. Support levels are at $715 and $712, with resistance at $722 and $725. Analyst sentiment is split evenly between buy and sell recommendations, reflecting uncertainty amid mixed news coverage.
The ETF's outlook is supported by strong historical performance and growth exposure, but risks include fee competitiveness and market volatility. Investors should weigh the divided analyst consensus against the fund's track record in technology and growth sectors.
TXG trades at $65.60, up 4.71% today, with a bullish technical signal and recent earnings beats. The stock shows improving fundamentals, with 2025 revenue at $642.82M and net loss narrowing to -$43.54M. Positive sentiment is driven by patent wins, Atera platform demand, and institutional interest, though valuation metrics like P/S of 13.58 and EV/EBITDA of 142.2 remain elevated.
Outlook is cautiously optimistic with upside potential from Atera execution, but risks include high valuation, persistent losses, and competitive pressures. Analyst consensus is mixed with a $50.56 price target below current levels, indicating near-term caution despite long-term growth prospects in genomics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
